Elucidating the Association of Epstein-Barr Virus and Multiple Sclerosis
Scott Newsome, DO, leads a panel discussion with thought leaders on the implications of findings from a recently published longitudinal [...]
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
The Effects of Isoniazid on Patients with Multiple Sclerosis
Multiple sclerosis is a common disease of unknown etiology, variable course, and undefinable prognosis for the individual (1). The [...]
Some Contributions of the Department of Veterans Affairs to the Epidemiology of Multiple Sclerosis
Dr. John F. Kurtzke is a well-known and beloved figure in the CMSC and, of course, the man behind the scale which bears his name. His [...]
MS in Uruguay
En Uruguay, la prevalencia de la Esclerosis Múltiple en el Uruguay, es la más alta de América del Sur, América Central y México [...]
Argentine Patagonia: Prevalence and Clinical Features of Multiple Sclerosis
There are few studies reporting multiple sclerosis prevalence rates in the Buenos Aires region, Argentina (latitude 34ºS) (between [...]
The Basics of Genetics in Multiple Sclerosis
Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. The etiology of multiple sclerosis is [...]